Selective Thyroid Hormone Receptor-Beta Agonists, Processes for Manufacturing or Relating to Same, and Products Containing Same (Violation)

337-TA-1352
ITC
Appeal NumberLogin To View
Unfair ActLogin To View
Docket Number-
Filing DateDec 29, 2022
Institution DateFeb 9, 2023
Termination DateLogin To View
Case LengthLogin To View
Patent0
-
Trademark
-
Complainant
2
Viking Therapeutics Inc.
Respondent
6
Gannex Pharma Co. Ltd.
Ascletis Pharmaceuticals Co. Ltd.
Jinzi Jason
Ascletis Pharma Inc.
ITC report image

Empower your practice with Patexia ITC IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a ITC Attorney & Experts?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.